EP4073049A1 - Novel crystalline forms of flufenacet, methods for their preparation and use of the same - Google Patents
Novel crystalline forms of flufenacet, methods for their preparation and use of the sameInfo
- Publication number
- EP4073049A1 EP4073049A1 EP21731371.7A EP21731371A EP4073049A1 EP 4073049 A1 EP4073049 A1 EP 4073049A1 EP 21731371 A EP21731371 A EP 21731371A EP 4073049 A1 EP4073049 A1 EP 4073049A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- flufenacet
- crystalline modification
- crystalline
- solvent system
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000005531 Flufenacet Substances 0.000 title claims abstract description 143
- IANUJLZYFUDJIH-UHFFFAOYSA-N flufenacet Chemical compound C=1C=C(F)C=CC=1N(C(C)C)C(=O)COC1=NN=C(C(F)(F)F)S1 IANUJLZYFUDJIH-UHFFFAOYSA-N 0.000 title claims abstract description 143
- 238000000034 method Methods 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title description 12
- 238000012986 modification Methods 0.000 claims abstract description 96
- 230000004048 modification Effects 0.000 claims abstract description 96
- 239000000203 mixture Substances 0.000 claims abstract description 77
- 239000002904 solvent Substances 0.000 claims abstract description 66
- 239000000843 powder Substances 0.000 claims abstract description 16
- 238000002844 melting Methods 0.000 claims abstract description 15
- 230000008018 melting Effects 0.000 claims abstract description 15
- 230000008635 plant growth Effects 0.000 claims abstract description 15
- 238000001228 spectrum Methods 0.000 claims abstract description 13
- 238000000113 differential scanning calorimetry Methods 0.000 claims abstract description 8
- 230000001376 precipitating effect Effects 0.000 claims abstract description 4
- 241000196324 Embryophyta Species 0.000 claims description 47
- 230000011514 reflex Effects 0.000 claims description 18
- 239000013078 crystal Substances 0.000 claims description 16
- 239000004546 suspension concentrate Substances 0.000 claims description 16
- -1 colourants Substances 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 230000001747 exhibiting effect Effects 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- 239000003208 petroleum Substances 0.000 claims description 12
- 239000004562 water dispersible granule Substances 0.000 claims description 12
- 238000009835 boiling Methods 0.000 claims description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- 231100000419 toxicity Toxicity 0.000 claims description 9
- 230000001988 toxicity Effects 0.000 claims description 9
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 8
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 8
- 239000002518 antifoaming agent Substances 0.000 claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 claims description 8
- 230000005855 radiation Effects 0.000 claims description 8
- 239000008096 xylene Substances 0.000 claims description 8
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 7
- 150000001924 cycloalkanes Chemical class 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 7
- 240000004160 Capsicum annuum Species 0.000 claims description 6
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 125000000524 functional group Chemical group 0.000 claims description 6
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 230000001464 adherent effect Effects 0.000 claims description 5
- 229930007927 cymene Natural products 0.000 claims description 5
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 5
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- 240000006122 Chenopodium album Species 0.000 claims description 4
- 235000009344 Chenopodium album Nutrition 0.000 claims description 4
- 241000207199 Citrus Species 0.000 claims description 4
- 244000175448 Citrus madurensis Species 0.000 claims description 4
- 241001672694 Citrus reticulata Species 0.000 claims description 4
- 241001289540 Fallopia convolvulus Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- 241000209082 Lolium Species 0.000 claims description 4
- 241000628106 Oxygonum sinuatum Species 0.000 claims description 4
- 244000062793 Sorghum vulgare Species 0.000 claims description 4
- 235000003595 Tagetes minuta Nutrition 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 4
- 239000004491 dispersible concentrate Substances 0.000 claims description 4
- 239000002270 dispersing agent Substances 0.000 claims description 4
- 239000004495 emulsifiable concentrate Substances 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 239000004548 suspo-emulsion Substances 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 3
- 244000299507 Gossypium hirsutum Species 0.000 claims description 3
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 3
- 240000006240 Linum usitatissimum Species 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 3
- 150000001555 benzenes Chemical class 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 3
- 235000013339 cereals Nutrition 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 235000009973 maize Nutrition 0.000 claims description 3
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 claims description 3
- 235000012015 potatoes Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 244000291564 Allium cepa Species 0.000 claims description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 2
- 240000001592 Amaranthus caudatus Species 0.000 claims description 2
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims description 2
- 244000144725 Amygdalus communis Species 0.000 claims description 2
- 244000003416 Asparagus officinalis Species 0.000 claims description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 2
- 235000010960 Atriplex hastata Nutrition 0.000 claims description 2
- 235000007319 Avena orientalis Nutrition 0.000 claims description 2
- 244000075850 Avena orientalis Species 0.000 claims description 2
- 241000167854 Bourreria succulenta Species 0.000 claims description 2
- 244000056139 Brassica cretica Species 0.000 claims description 2
- 235000003351 Brassica cretica Nutrition 0.000 claims description 2
- 240000007124 Brassica oleracea Species 0.000 claims description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 2
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 2
- 241000220244 Capsella <angiosperm> Species 0.000 claims description 2
- 235000011305 Capsella bursa pastoris Nutrition 0.000 claims description 2
- 240000008867 Capsella bursa-pastoris Species 0.000 claims description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 claims description 2
- 235000008645 Chenopodium bonus henricus Nutrition 0.000 claims description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 2
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 2
- 244000183685 Citrus aurantium Species 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 235000004332 Citrus madurensis Nutrition 0.000 claims description 2
- 235000001759 Citrus maxima Nutrition 0.000 claims description 2
- 244000276331 Citrus maxima Species 0.000 claims description 2
- 240000004307 Citrus medica Species 0.000 claims description 2
- 235000007438 Citrus mitis Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- 240000002319 Citrus sinensis Species 0.000 claims description 2
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 2
- 241000555678 Citrus unshiu Species 0.000 claims description 2
- 235000017102 Citrus x nobilis Nutrition 0.000 claims description 2
- 244000295848 Citrus x nobilis Species 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- 241000333459 Citrus x tangelo Species 0.000 claims description 2
- 241000218631 Coniferophyta Species 0.000 claims description 2
- 240000000491 Corchorus aestuans Species 0.000 claims description 2
- 235000011777 Corchorus aestuans Nutrition 0.000 claims description 2
- 235000010862 Corchorus capsularis Nutrition 0.000 claims description 2
- 241000219112 Cucumis Species 0.000 claims description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 2
- 235000009849 Cucumis sativus Nutrition 0.000 claims description 2
- 240000008067 Cucumis sativus Species 0.000 claims description 2
- 241000219122 Cucurbita Species 0.000 claims description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 2
- 241000219104 Cucurbitaceae Species 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 235000017896 Digitaria Nutrition 0.000 claims description 2
- 241001303487 Digitaria <clam> Species 0.000 claims description 2
- 235000002673 Dioscorea communis Nutrition 0.000 claims description 2
- 235000007351 Eleusine Nutrition 0.000 claims description 2
- 241000209215 Eleusine Species 0.000 claims description 2
- 241000508725 Elymus repens Species 0.000 claims description 2
- 239000004606 Fillers/Extenders Substances 0.000 claims description 2
- 235000017317 Fortunella Nutrition 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 235000018914 Galinsoga parviflora Nutrition 0.000 claims description 2
- 244000214240 Galinsoga parviflora Species 0.000 claims description 2
- 241000208818 Helianthus Species 0.000 claims description 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 2
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 2
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- 240000004322 Lens culinaris Species 0.000 claims description 2
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 244000070406 Malus silvestris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000003447 Pistacia vera Nutrition 0.000 claims description 2
- 240000006711 Pistacia vera Species 0.000 claims description 2
- 235000010582 Pisum sativum Nutrition 0.000 claims description 2
- 240000004713 Pisum sativum Species 0.000 claims description 2
- 240000005809 Prunus persica Species 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 241000220324 Pyrus Species 0.000 claims description 2
- 241000220259 Raphanus Species 0.000 claims description 2
- 235000000241 Raphanus raphanistrum Nutrition 0.000 claims description 2
- 244000286177 Raphanus raphanistrum Species 0.000 claims description 2
- 241000220317 Rosa Species 0.000 claims description 2
- 240000007651 Rubus glaucus Species 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 2
- 235000007238 Secale cereale Nutrition 0.000 claims description 2
- 244000082988 Secale cereale Species 0.000 claims description 2
- 235000005775 Setaria Nutrition 0.000 claims description 2
- 241000232088 Setaria <nematode> Species 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 2
- 244000300264 Spinacia oleracea Species 0.000 claims description 2
- 240000002670 Tagetes lucida Species 0.000 claims description 2
- 241000429223 Tagetes minuta Species 0.000 claims description 2
- 240000006909 Tilia x europaea Species 0.000 claims description 2
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 2
- 235000019714 Triticale Nutrition 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 2
- 241000219094 Vitaceae Species 0.000 claims description 2
- 235000020224 almond Nutrition 0.000 claims description 2
- 239000007798 antifreeze agent Substances 0.000 claims description 2
- 235000021016 apples Nutrition 0.000 claims description 2
- 235000021028 berry Nutrition 0.000 claims description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 2
- 235000021029 blackberry Nutrition 0.000 claims description 2
- 235000009120 camo Nutrition 0.000 claims description 2
- 239000001511 capsicum annuum Substances 0.000 claims description 2
- 239000001728 capsicum frutescens Substances 0.000 claims description 2
- 235000005607 chanvre indien Nutrition 0.000 claims description 2
- 235000019693 cherries Nutrition 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 235000021021 grapes Nutrition 0.000 claims description 2
- 239000011487 hemp Substances 0.000 claims description 2
- 239000004571 lime Substances 0.000 claims description 2
- 235000019713 millet Nutrition 0.000 claims description 2
- 235000010460 mustard Nutrition 0.000 claims description 2
- 235000021017 pears Nutrition 0.000 claims description 2
- 235000020233 pistachio Nutrition 0.000 claims description 2
- 235000021018 plums Nutrition 0.000 claims description 2
- 235000021039 pomes Nutrition 0.000 claims description 2
- 235000021013 raspberries Nutrition 0.000 claims description 2
- 239000004575 stone Substances 0.000 claims description 2
- 235000021012 strawberries Nutrition 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 235000013706 tagetes lucida Nutrition 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 241000228158 x Triticosecale Species 0.000 claims description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 claims 2
- 239000000243 solution Substances 0.000 description 26
- 238000009472 formulation Methods 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 7
- 230000001276 controlling effect Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000003905 agrochemical Substances 0.000 description 6
- 230000002363 herbicidal effect Effects 0.000 description 6
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000239250 Copepoda Species 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 244000038559 crop plants Species 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920001732 Lignosulfonate Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000004996 alkyl benzenes Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000002178 crystalline material Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- NVVZQXQBYZPMLJ-UHFFFAOYSA-N formaldehyde;naphthalene-1-sulfonic acid Chemical compound O=C.C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 NVVZQXQBYZPMLJ-UHFFFAOYSA-N 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000000634 powder X-ray diffraction Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- WHOZNOZYMBRCBL-OUKQBFOZSA-N (2E)-2-Tetradecenal Chemical compound CCCCCCCCCCC\C=C\C=O WHOZNOZYMBRCBL-OUKQBFOZSA-N 0.000 description 1
- SQLPTSMJAQPVKR-UHFFFAOYSA-N 2-methylsulfonyl-5-(trifluoromethyl)-1,3,4-thiadiazole Chemical compound CS(=O)(=O)C1=NN=C(C(F)(F)F)S1 SQLPTSMJAQPVKR-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001557 Albinism Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229910002483 Cu Ka Inorganic materials 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 239000004113 Sepiolite Substances 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L Zinc chloride Inorganic materials [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- ZCZSIDMEHXZRLG-UHFFFAOYSA-N acetic acid heptyl ester Natural products CCCCCCCOC(C)=O ZCZSIDMEHXZRLG-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Substances OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000010352 biotechnological method Methods 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical class [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- JPXGPRBLTIYFQG-UHFFFAOYSA-N heptan-4-yl acetate Chemical compound CCCC(CCC)OC(C)=O JPXGPRBLTIYFQG-UHFFFAOYSA-N 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 150000005673 monoalkenes Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- RISGISSUGUGJMO-UHFFFAOYSA-N n-(4-fluorophenyl)-2-hydroxy-n-propan-2-ylacetamide Chemical compound OCC(=O)N(C(C)C)C1=CC=C(F)C=C1 RISGISSUGUGJMO-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940044654 phenolsulfonic acid Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000003620 semiochemical Substances 0.000 description 1
- 229910052624 sepiolite Inorganic materials 0.000 description 1
- 235000019355 sepiolite Nutrition 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/13—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P13/00—Herbicides; Algicides
Definitions
- the present invention relates to novel crystalline forms of N- (4-Fluorophenyl) -N-isopropyl-2- ⁇ [5- (trifluoromethyl) -1, 3, 4-thiadiazol-2-yl] oxy ⁇ acetamide (flufenacet) . Further, the present invention relates to methods for the preparation of the novel crystalline forms of flufenacet. Still further, the present invention relates to the use of the crystalline forms of flufenacet in agrochemical preparations and for the control of unwanted plant growth.
- N- (4-Fluorophenyl) -N-isopropyl-2- ⁇ [5- (trifluoromethyl) -1, 3, 4-thiadiazol-2-yl] oxy ⁇ acetamide having the common name flufenacet, is an oxyacetamide herbicide, highly effective against a wide range of broadleaf and grassy weeds.
- Flufenacet has the molecular formula C 14 H 13 F 4 N 3 O 2 S and its chemical structure can be represented as follows:
- Flufenacet and formulations containing flufenacet are available commercially. However, it has been found that the commercially available flufenacet exhibits a significant toxicity toward the aquatic species, such as fish. Therefore, there is a need to improve the performance of flufenacet and render flufenacet more environmentally acceptable, in particular to decrease the toxicity of flufenacet to animals, such as aquatic species of animals.
- crystalline modification II flufenacet can exist in a crystalline form, herein termed “crystalline modification II” , which has been found to exhibit a lower toxicity toward aquatic species of animals. This lower toxicity provides significant advantages when using flufenacet in the crystalline modification II when preparing agrochemical formulations and the use thereof in the control of unwanted plant growth.
- crystalline modification has the same meaning with the term “crystalline form” .
- the present invention provides a crystalline modification II of flufenacet, the crystalline modification exhibiting at least three of the following reflexes, in any combination, as 2 ⁇ 0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-K ⁇ radiation at 25 °C:
- XRD X-ray powder diffractogram
- the crystalline modification II of flufenacet according to the first aspect of the invention exhibits the following reflexes:
- the crystalline modification II of flufenacet according to the first aspect of the invention exhibits the following reflexes:
- the crystalline modification II of flufenacet according to the first aspect of the invention exhibits the following reflexes:
- the crystalline modification II of flufenacet according to the first aspect of the invention exhibits the following reflexes:
- the present invention provides a crystalline modification II of flufenacet, the crystalline modification exhibiting an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1 , ⁇ 0.2%) of one or more of 1676.95, 1484.76, 1309.70, 1151.70, 1033.94 and 943.23 cm -1 .
- IR infrared
- the present invention provides a crystalline modification II of flufenacet, the crystalline modification exhibiting a melting point of from 77.1°C.
- a crystalline modification II of flufenacet exhibiting a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 76.0°C and peak maximum at 77.1°C, more preferably with a melting enthalpy of 65.43 J/g.
- DSC differential scanning calorimetry
- the crystalline modification II of flufenacet is useful in controlling plant growth. Accordingly, the present invention also provides compositions for controlling plant growth, such as weeds, comprising the crystalline modification II of flufenacet.
- flufenacet may be employed on its own, as a mixture with auxiliaries and carriers and/or as a mixture with other active compounds.
- the present invention provides the use of the crystalline modification II of flufenacet in the control of undesirable plant growth.
- the present invention provide a method for controlling plant growth at a locus, the method comprising applying to the locus the crystalline modification II of flufenacet.
- Figure 1 is an X-ray powder diffraction (XRD) spectrum of the crystalline modification II of flufenacet;
- Figure 2 is an infrared (IR) spectrum of the crystalline modification II of flufenacet.
- Figure 3 is a Differential Scanning Calorimetry (DSC) spectrum of the crystalline modification II of flufenacet.
- the crystalline modification II of flufenacet is readily comminuted and/or ground. This facilitates the preparation of a wide range of agrochemical formulations, such as suspension concentrates (SC) , oil-based suspension concentrates (OD) , water-dispersible granules (WG) and water-soluble granules (SG) .
- SC suspension concentrates
- OD oil-based suspension concentrates
- WG water-dispersible granules
- SG water-soluble granules
- the crystalline modification II of flufenacet may be characterized as exhibiting at least three of the following reflexes, in any combination, as 2 ⁇ 0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-K ⁇ radiation at 25 °C:
- XRD X-ray powder diffractogram
- the crystalline modification II of flufenacet of the present invention is characterized by an X-ray powder diffractogram having at least three of the reflexes indicated above.
- the crystalline modification II of flufenacet is one having at least four of the aforementioned reflexes, more preferably at least five of the aforementioned reflexes, still more preferably six, more preferably still seven, especially eight of the aforementioned reflexes, again in any combination thereof.
- the crystalline modification II of flufenacet exhibits at least three, more preferably four, still more preferably five, more preferably still six, especially seven, of the following reflexes, in any combination, as 2 ⁇ 0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-K ⁇ radiation at 25°C:
- XRD X-ray powder diffractogram
- the crystalline modification II of flufenacet exhibits all of the following reflexes, in any combination, as 2 ⁇ 0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-K ⁇ radiation at 25°C:
- a preferred crystalline modification II of flufenacet exhibits all of the reflexes listed above, in particular all of the reflexes (1) to (13) .
- the X-ray powder diffractogram of the crystalline modification II of flufenacet shown in Figure 1 was taken using a diffractometer with a reflection geometry in the range from 3° to 60° with increments of 0.03° using Cu-Ka radiation at 25°C.
- the present invention provides a crystalline modification II of flufenacet exhibiting an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1 , ⁇ 0.2%) of one or more of the following: 1676.95, 1484.76, 1309.70, 1151.70, 1033.94 and 943.23 cm -1 .
- IR infrared
- a preferred crystalline modification II of flufenacet exhibits an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1 , ⁇ 0.2%) of two or more, preferably three or more, more preferably four of the following: 1676.95, 1484.76, 1309.70, 1151.70, 1033.94 and 943.23 cm -1 .
- a preferred crystalline modification II of flufenacet exhibits an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1 , ⁇ 0.2%) having all of the aforementioned vibration peaks.
- the crystalline modification II of flufenacet exhibits an X-ray powder diffractogram as described above for the first aspect of the invention and an infrared (IR) spectrum as described above for the second aspect of the present invention.
- a third aspect of the present invention provides a crystalline modification II of flufenacet, exhibiting a melting point of about 77.1°C.
- the crystalline modification II of flufenacet exhibits a melting point of about 77.1°C according to this third aspect of the invention, together with an X-ray powder diffractogram as described above for the first aspect of the invention and/or an infrared (IR) spectrum as described above for the second aspect of the present invention.
- a fourth aspect of the present invention provides a crystalline modification II of flufenacet exhibiting a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 76.0°C and peak maximum at 77.1°C, more preferably with a melting enthalpy of 65.43 J/g.
- DSC differential scanning calorimetry
- the crystalline modification II of flufenacet exhibits a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 76.0°Cand peak maximum at 77.1°C according to this fourth aspect of the invention, together with an X-ray powder diffractogram as described above for the first aspect of the invention and/or an infrared (IR) spectrum as described above for the second aspect of the present invention and/or a melting point as described above for the third aspect of the present invention.
- DSC differential scanning calorimetry
- the crystalline modification II of flufenacet is characterized by an X-ray powder diffraction pattern substantially as shown in Figure 1, and/or characterized by an IR spectrum substantially as shown in Figure 2, and/or characterized by a DSC thermogram substantially as shown in Figure 3, and/or by a melting point of about 77.1°C.
- Flufenacet is available commercially. Methods for preparing flufenacet are well known in the art. One particularly suitable method for preparing flufenacet is described in US 4,968,342.
- the present invention provides a method for preparing a crystalline modification II of flufenacet, the method comprising the steps of:
- the solution of flufenacet may be provided in step i) by heating flufenacet in the solvent system while stirring until dissolved completely.
- the form of flufenacet used in this step may be any form of flufenacet other than the crystalline modification II.
- flufenacet heated in the solvent system in step i) is amorphous flufenacet.
- the solvent system employed in the method is one in which flufenacet is readily soluble and is one from which the crystalline modification II of flufenacet is crystallised. In this respect, it has been found that appropriate selection of the solvent system is required in order to yield flufenacet in the crystalline modification II.
- the solvent system yielding the crystalline modification II of flufenacet comprises one or more solvents selected from aliphatic, cycloaliphatic or aromatic hydrocarbons, cymene, petroleum fractions, and petroleum ether.
- Suitable aliphatic hydrocarbon solvents are known in the art.
- Preferred aliphatic hydrocarbon solvents include alkanes, more preferably C 5 to C 10 alkanes, especially C 5 to C 9 alkanes, for example pentane, hexane, heptane, octane and nonane.
- the aliphatic hydrocarbon solvents may be straight chained or branched, with straight chain or normal hydrocarbons being preferred, for example n-pentane, n-hexane, n-heptane, n-octane and n-nonane.
- Suitable cycloaliphatic hydrocarbon solvents are known in the art and include cycloalkanes, preferably C 5 to C 8 cycloalkanes.
- the cycloalkanes may be substituted, for example bearing one or more substituents, such as C 1 to C 4 alkyl-substituted cycloalkanes, especially cycloalkanes bearing one or more methyl substituents.
- Preferred cycloaliphatic hydrocarbon solvents include cyclohexane and substituted-cyclohexane, for example methylcyclohexane.
- aromatic hydrocarbon solvents are known in the art.
- the aromatic hydrocarbons may bear one or more substituents, such as one or more C 1 to C 4 alkyl moieties.
- Preferred aromatic hydrocarbon solvents are benzene and derivatives of benzene, such as cymene, toluene and xylene.
- Suitable petroleum fractions for use as solvents are known in the art.
- Preferred petroleum fractions are those having a boiling point of from 50 to 200°C, more preferably from 60 to 190°C, such as ligroin or heavy naphtha having a boiling point of from 90 to 140°C or light naphtha having a boiling point from 60 to 80°C.
- One particularly preferred solvent is xylene.
- the present invention provides the use of a solvent system to prepare crystalline flufenacet having reduced toxicity, wherein the solvent system comprises one or more solvents selected from aliphatic, cycloaliphatic or aromatic hydrocarbons, petroleum fractions, and petroleum ether.
- the solvent system may consist essentially of a single solvent selected from the aforementioned solvents.
- the solvent system may comprise a mixture of two or more of the aforementioned solvents, for example a mixture of three or four solvents.
- a solution of flufenacet in the solvent system is provided.
- the solvent system may be heated to a temperature above room temperature, for example to a temperature from 25°C, more preferably to a temperature from 30°C.
- the solvent system may be heated to a temperature up to the boiling point of the solvent system, preferably up to 90°C, more preferably up to 80°C, still more preferably up to 70°C, more preferably still up to 60°, depending upon the solvent system being employed.
- the solvent system may be heated to a temperature of from 30 to 60°C.
- the flufenacet is preferably combined with the solvent system while stirring until the flufenacet starting material is dissolved completely.
- step ii) of the method flufenacet is caused to precipitate from the solution to yield the crystalline modification II of flufenacet. Any suitable technique for precipitating flufenacet from the solution provided in step i) may be used.
- the solution of flufenacet in the solvent system is cooled.
- the solution may be cooled to any suitable temperature to cause the crystalline modification II of flufenacet to crystallise out of the solution.
- the solution may be cooled to a temperature of down to -20°C, preferably down to -15°C.
- the solution may be cooled to a temperature of up to 10°C, more preferably up to 5°C. Cooling to a temperature in the range of from -15 to 5°C is preferred for many embodiments.
- precipitation may be facilitated by removing solvent from the solution, for example by applying a vacuum to the solution.
- seed crystals are added to the solution.
- the addition of seed crystals facilitates precipitation of the solute from the solution, as is known in the art.
- the seed crystals are crystals of flufenacet, more preferably crystals of the crystalline modification II of flufenacet.
- the amount of seed crystals added to the solution is typically in the range of from 0.001 to 10% by weight, preferably from 0.001% to 2.5% by weight, more preferably from 0.005 to 0.5%by weight, based on the weight of flufenacet present in the solution provided in step i) .
- the seed crystals are preferably added to the solution at a temperature below the boiling point of the solvent system.
- step iii) of the method the precipitated crystalline modification II of flufenacet is isolated or recovered from the solvent system. Any suitable technique may be used to recover the crystalline modification II of flufenacet, for example filtration, centrifugation and/or decantation.
- the isolated solid flufenacet is preferably washed one or more times with a solvent system comprising one or more solvents.
- the solvent system employed in the washing stage comprises one or more components of the solvent system of the solution provided in step (i) , as described hereinbefore. Washing is preferably carried out using the solvent system at a temperature from 0°C to room temperature, depending on the solubility of the crystalline form of flufenacet in the solvent, in order to minimize or avoid the loss of crystalline material in the corresponding washing solvent.
- flufenacet as an herbicide is known in the art and is used on a commercial scale. It has been found that the crystalline modification II of flufenacet is also active in controlling undesirable plant growth, such as weeds. Techniques of formulating and applying amorphous flufenacet are known in the art, for example as disclosed in the prior art documents described hereinbefore. These techniques can also be applied in an analogous manner to the crystalline modification II of flufenacet.
- the present invention further provides a herbicidal composition comprising the crystalline modification II of flufenacet as defined hereinbefore.
- the herbicidal composition generally comprises one or more auxiliary components, as described in more detail hereinafter.
- the herbicidal composition may comprise the crystalline modification II of flufenacet in any suitable amount, which may depend upon such factors as the type of formulation being employed.
- the composition comprises the crystalline modification II of flufenacet in an amount of from 5% by weight of the composition, preferably from 10% by weight of the composition, more preferably from 20%by weight of the composition.
- the composition comprises the crystalline modification II of flufenacet in an amount of about 50% by weight of the composition.
- the composition may be formulated in any suitable form.
- the composition is in the form of a suspension concentrate (SC) , an oil-based suspension concentrate (OD) , water-soluble granules (SG) , a dispersible concentrate (DC) , an emulsifiable concentrate (EC) , an emulsion seed dressing, a suspension seed dressing, granules (GR) , microgranules (MG) , a suspoemulsion (SE) or water-dispersible granules (WG) .
- SC suspension concentrate
- OD oil-based suspension concentrate
- DC dispersible concentrate
- EC emulsifiable concentrate
- emulsion seed dressing emulsion seed dressing
- GR granules
- MG microgranules
- SE suspoemulsion
- WG water-dispersible granules
- the composition is in the form of a suspension concentrate (SC) .
- the composition is in the form of water-dispersible granules (WG) .
- compositions are prepared by combining the crystalline modification II of flufenacet with one or more agriculturally acceptable auxiliaries.
- auxiliaries employed in the composition and their amounts will depend upon the type of formulation and/or the manner in which the formulation is to be applied by the end user.
- Suitable auxiliaries are customary formulation adjuvant or components, such as dispersants, wetting agents, emulsifiers, extenders, carriers, solvents, surfactants, stabilizers, anti-foam agents, anti-freeze agents, preservatives, antioxidants, colourants, thickeners, solid adherents and inert fillers.
- Such auxiliaries are known in the art and are commercially available. Their use in the formulation of the compositions of the present invention will be apparent to the person skilled in the art.
- Surfactants can be an emulsifier, dispersant or wetting agent of ionic or nonionic type.
- Examples which may be used include, but are not limited to, salts of polyacrylic acids, salts of lignosulphonic acid, salts of phenylsulphonic or naphthalenesulphonic acids, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols, especially alkylphenols, sulphosuccinic ester salts, taurine derivatives, especially alkyltaurates, or phosphoric esters of polyethoxylated phenols or alcohols.
- Liquid diluents include, but are not limited to, water, N, N-dimethylamide, dimethyl sulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, propylene carbonate, dibasic esters, paraffins, alkylbenzenes, alkyl naphthalenes, glycerine, triacetine, oils of olive, castor, linseed, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, acetates such as hexyl acetate, heptyl acetate and octyl acetate, and alcohols such methanol, cyclohexanol, decanol, benzyl and tetrahydrofurfuryl alcohol, and mixtures thereof.
- the composition may further comprise one or more polymeric stabilizers.
- Suitable polymeric stabilizers that may be used in the present invention include, but are not limited to, polypropylene, polyisobutylene, polyisoprene, copolymers of monoolefins and diolefins, polyacrylates, polystyrene, polyvinyl acetate, polyurethanes or polyamides. Suitable stabilizers are known in the art and are commercially available.
- the composition may further comprise one or more anti-foam agents.
- Suitable anti-foam agents include those substances which can normally be used for this purpose in agrochemical compositions and will be readily apparent to the person skilled in the art. Suitable anti-foam agents are known in the art and are commercially available. Particularly preferred anti-foam agents are mixtures of polydimethylsiloxanes and perfluroalkylphosphonic acids, such as the silicone anti-foam agents (for example commercially available from GE or Compton) . Other examples of anti-foam agents are fatty acids, tallow, and sodium salts.
- the composition may further comprise one or more preservatives.
- Suitable preservatives include those substances which can normally be used for this purpose in agrochemical compositions of this type and again are well known in the art. Suitable examples that may be mentioned include (commercially available from Bayer AG) and (commercially available from Bayer AG) .
- the composition may further comprise one or more antioxidants.
- Suitable antioxidants are substances which can normally be used for this purpose in agrochemical compositions, as is known in the art. Preference is given, for example, to butylated hydroxytoluene.
- the composition may further comprise one or more solid adherents.
- adherents are known in the art and available commercially.
- Suitable solid adherents include organic adhesives, including tackifiers, such as celluloses of substituted celluloses, natural and synthetic polymers in the form of powders, granules, or lattices, and inorganic adhesives such as gypsum, silica, or cement.
- the composition may further comprise one or more inert fillers.
- inert fillers are known in the art and available commercially. Suitable fillers include, for example, natural ground minerals, such as kaolins, aluminas, talc, chalk, quartz, attapulgite, montmorillonite, and diatomaceous earth, or synthetic ground minerals, such as highly dispersed silicic acid, aluminum oxide, silicates, and calcium phosphates and calcium hydrogen phosphates.
- Suitable inert fillers for granules include, for example, crushed and fractionated natural minerals, such as calcite, marble, pumice, sepiolite, and dolomite, or synthetic granules of inorganic and organic ground materials, as well as granules of organic material, such as sawdust, coconut husks, corn cobs, and tobacco stalks.
- inert fillers also include sodium tripolyphosphate and sucrose.
- Solid diluents can be water-soluble or water-insoluble.
- Water-soluble solid diluents include, but are not limited to, salts such as alkali metal phosphates (for example sodium dihydrogen phosphate) , alkaline earth phosphates, sulfates of sodium, potassium, magnesium and zinc, sodium and potassium chloride, sodium acetate, sodium carbonate and sodium benzoate, and sugars and sugar derivatives such as sorbitol, lactose, sucrose and mannitol.
- Examples of water-insoluble solid diluents include, but are not limited to clays, synthetic and diatomaceous silicas, calcium and magnesium silicates, titanium dioxide, aluminum, calcium and zinc oxide, and mixtures thereof.
- Wetting agents include, but are not limited to, alkyl sulfosuccinates, laureates, alkyl sulfates, phosphate esters, acetylenic diols, ethoxyfluornated alcohols, ethoxylated silicones, alkyl phenol ethyoxylates, benzene sulfonates, alkyl-substituted benzene sulfonates, alkyl a-olefin sulfonates, naphthalene sulfonates, alkyl-substituted naphthalene sulfonates, condensates of naphthalene sulfonates and alkyl-substituted naphthalene sulfonates with formaldehyde, and alcohol ethoxylates, and mixtures thereof. Alkyl naphthalene sulphonates, sodium salts are particularly useful for the composition
- Dispersants include, but are not limited to, sodium, calcium and ammonium salts of ligninsulfonates (optionally polyethoxylated) ; sodium and ammonium salts of maleic anhydride copolymers; sodium salts of condensed phenolsulfonic acid; and naphthalene sulfonate-formaldehyde condensates.
- Ligninsulfonates such as sodium ligninsulfonates are particularly useful for the composition of the invention.
- Naphthalene sulfonate-formaldehyde condensates such as naphthalenesulfonic acid, polymers with formaldehyde, and sodium salts are particularly useful for the composition of the invention.
- Thickening agents include, but are not limited to, guar gum, pectin, casein, carrageenan, xanthan gum, alginates, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and carboxymethylcellulose, and mixtures thereof.
- Synthetic thickening agents include derivatives of the former categories, and also polyvinyl alcohols, polyacrylamides, polyvinylpyrrolidones, various polyethers, their copolymers, as well as polyacrylic acids and their salts, and mixtures thereof. Alkylpolyvinylpyrrolidones are particularly useful for the composition of the invention.
- formulation components can also be used in the present invention such as dyes, drying agents, and the like. These components and their uses are known to one skilled in the art.
- composition of the present invention may comprise the crystalline modification II of flufenacet as the sole active ingredient.
- active components such as attractants, sterilizing agents, bactericides, acaricides, nematicides, fungicides, growth-regulating substances, herbicides, safeners, fertilizers, semiochemicals, insecticides or agents for improving plant properties.
- the present invention also provides a method for controlling unwanted plant growth, comprising applying to the plant, plant part, or surroundings of the plant, a herbicidally effective amount of the crystalline modification II of flufenacet as hereinbefore described.
- the crystalline modification II of flufenacet is preferably applied in the form of a composition as hereinbefore described.
- compositions of the present invention are known in the art and will be understood by the person skilled in the art. Techniques include diluting or dispersing the composition in a suitable diluent or carrier liquid, in particular water, and applying the composition by spraying.
- plants are to be understood as meaning all plants and plant populations such as desired and undesired wild plants or crop plants, including naturally occurring crop plants.
- Crop plants can be plants which can be obtained by conventional breeding and optimization methods, by biotechnological and genetic engineering methods, or by combinations of these methods, including the transgenic plants and the plant cultivars which may or may not be protected by plant breeders' rights.
- Plant parts are to be understood as meaning all parts and organs of plants above and below the ground, such as shoots, leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes.
- Harvested materials, and vegetative and generative propagation materials for example, cuttings, tubers, meristem tissue, rhizomes, offsets, seeds, single and multiple plant cells and any other plant tissues, are also included.
- compositions or formulations of the invention can be carried out directly or by allowing the compositions or formulations to act on their surroundings, habitat or storage space by the customary treatment methods known in the art.
- customary treatment methods include dipping, spraying, vaporizing, fogging, broadcasting, painting on in the case of propagation material, and applying one or more coats particularly in the case of seeds.
- the benefits of the present invention are particularly advantageous when the crystalline modification II of flufenacet or its herbicidal composition are applied to kill weeds in crops of useful plants, such as cereals, for example wheat, barley, rye, oats, maize, rice, sorghum, triticale and related crops; fruit, such as pomes, stone fruit and soft fruit, such as apples, grapes, pears, plums, peaches, almonds, pistachio, cherries, and berries, for example strawberries, raspberries and blackberries, bell pepper, red pepper; leguminous plants, for example beans, lentils, peas and soybeans; oil plants, such as rape, mustard and sunflowers; cucurbitaceae, such as marrows, cucumbers and melons; fiber plants, for example cotton, flax, hemp and jute; citrus, such as calamondin, citrus citron, citrus hybrids, including chironja, tangelo and tangor, grapefruit, kumquat,
- the invention may be used to control a wide range of undesired plants, including broadleaf plants and grassy weeds.
- the broadleaf weeds include such plants as shepherds purse (Capsella bursapastories) , fat hen (Chenopodium album) , double thorn (Oxygonum sinuatum) , black bind weed (Polygonum convolvulus) , Mexican marigold (Tagetes minuta) , gallant soldier (Galinsogo parviflora) , and white charlock (Raphanus raphanastrium) .
- the grassy weeds include such plants as foxtail (Setaria spp. ) , wild finder millet (Eleusine spp. ) , couch grass (Digitaria spp. ) and rye grass (Lolium spp. ) .
- references to properties are, unless stated otherwise, to properties measured under ambient conditions, i.e. at atmospheric pressure and at a temperature of about 20°C.
- the term “about” or “around” when used in connection with a numerical amount or range means somewhat more or somewhat less than the stated numerical amount or range, and for example to a deviation of ⁇ 10% of the stated numerical amount or endpoint of the range.
- “Surrounding, ” as used herein, refers to the place on which the plants are growing, the place on which the plant propagation materials of the plants are sown or the place on which the plant propagation materials of the plants will be sown.
- Precipitation refers to the sedimentation of a solid material (a precipitate) , including the sedimentation of a crystalline material, from a liquid solution in which the solid material is present in amounts greater than its solubility in the amount of liquid solution.
- herbicidally effective amount refers to the quantity of such a compound or combination of such compounds that is capable of producing a controlling effect on the growth of plants.
- the controlling effects include all deviation from the natural development of the target plants, for example killing, retardation of one or more aspects of the development and growth of the plant, leaf burn, albinism, dwarfing and the like.
- Flufenacet was prepared generally in accordance with the method of Example 1 of US 4,968,342, as follows:
- the solid flufenacet product was isolated by filtering with suction. Flufenacet obtained was amorphous.
- Flufenacet prepared in Example 1 (10 g) was placed in a 3 neck round bottom flask, together with xylene (60 mL) . The resulting mixture was heated to a temperature of from 30 to 60°C while stirring until the flufenacet had dissolved completely. Thereafter, the solution was slowly cooled to a temperature of from -15°C to 5°C. Upon cooling, fine crystals formed. The slurry of crystals and solution was stirred at room temperature for 2 hours. Thereafter, the slurry was filtered and washed with xylene (3 mL) . The filtered crystals were dried under a vacuum at room temperature in order to remove the xylene traces from the crystalline product.
- the crystalline product thus obtained had a purity of >98% and the product recovered as crystals was found to be not less than 80% yield.
- the crystal product was analyzed by IR spectrometry, XRD and DSC and found to be crystalline modification II of flufenacet as shown in Figures 1, 2 and 3, respectively.
- the IR spectrum of the crystalline flufenacet exhibited the functional group characteristic vibrations peaks at wavenumbers of one or more of about 1676.95, 1484.78, 1309.70, 1151.70, 1033.94 and 943.23 cm -1 , as shown in Figure 2.
- DSC Differential scanning calorimetry
- a suspension concentrate (SC) formulation was prepared as follows:
- Example 2 To provide a comparison, the procedure of Example 2 above was followed to prepare crystalline flufenacet using a range of different solvents.
- the solvent employed in each case is indicated in Table 3 below.
- Copepods (A clausi) were placed in culture vessels (2.5 L plastic buckets) and maintained at 14 ⁇ 1°C in a temperature-controlled room under conditions of dim light, with a photoperiod of 14 hours light and 10 hours dark.
- test end point was immobility of the animal, identified by a lack of movement when gently prodded or blown with a stream of water.
- Acute EC50 values were calculated using Probit or Spearman-Karber analyses using Tox Calc.
- the crystalline modification II of flufenacet exhibits a significantly lower toxicity than amorphous flufenacet and other crystalline forms of flufenacet.
Abstract
Description
- CROSS REFERENCE TO RELATED APPLICATIONS
- This application claims the priority of GB1918401.9, filed on October 6, 2020, titled with “NOVEL CRYSTALLINE FORMS OF FLUFENACET, METHODS FOR THEIR PREPARATION AND USE OF THE SAME” , and the disclosure of which is hereby incorporated by reference.
- The present invention relates to novel crystalline forms of N- (4-Fluorophenyl) -N-isopropyl-2- { [5- (trifluoromethyl) -1, 3, 4-thiadiazol-2-yl] oxy} acetamide (flufenacet) . Further, the present invention relates to methods for the preparation of the novel crystalline forms of flufenacet. Still further, the present invention relates to the use of the crystalline forms of flufenacet in agrochemical preparations and for the control of unwanted plant growth.
- N- (4-Fluorophenyl) -N-isopropyl-2- { [5- (trifluoromethyl) -1, 3, 4-thiadiazol-2-yl] oxy} acetamide, having the common name flufenacet, is an oxyacetamide herbicide, highly effective against a wide range of broadleaf and grassy weeds. Flufenacet has the molecular formula C 14H 13F 4N 3O 2S and its chemical structure can be represented as follows:
-
- Flufenacet and formulations containing flufenacet are available commercially. However, it has been found that the commercially available flufenacet exhibits a significant toxicity toward the aquatic species, such as fish. Therefore, there is a need to improve the performance of flufenacet and render flufenacet more environmentally acceptable, in particular to decrease the toxicity of flufenacet to animals, such as aquatic species of animals.
- SUMMARY
- It is known that some organic compounds exist in only one crystalline form, while other compounds can exist in two or more crystalline forms. It is not possible to predict the number of different crystalline forms a given compound will have, nor the physical, chemical and biological properties of the different crystalline forms, which may be markedly different.
- It has now been discovered that flufenacet can exist in a crystalline form, herein termed “crystalline modification II” , which has been found to exhibit a lower toxicity toward aquatic species of animals. This lower toxicity provides significant advantages when using flufenacet in the crystalline modification II when preparing agrochemical formulations and the use thereof in the control of unwanted plant growth. In the context, the term “crystalline modification” has the same meaning with the term “crystalline form” .
- Accordingly, in a first aspect, the present invention provides a crystalline modification II of flufenacet, the crystalline modification exhibiting at least three of the following reflexes, in any combination, as 2θ±0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-Kα radiation at 25 ℃:
- 2θ = 10.592 ± 0.2 (1)
- 2θ = 14.414 ± 0.2 (2)
- 2θ = 15.582 ± 0.2 (3)
- 2θ = 17.930 ± 0.2 (4)
- 2θ = 18.421 ± 0.2 (5)
- 2θ = 18.812 ± 0.2 (6)
- 2θ = 19.205 ± 0.2 (7)
- 2θ = 20.727 ± 0.2 (8)
- 2θ = 23.888 ± 0.2 (9)
- 2θ = 27.017 ± 0.2 (10)
- 2θ = 29.010 ± 0.2 (11)
- 2θ = 29.336 ± 0.2 (12)
- 2θ = 35.500 ± 0.2 (13) .
- In one preferred embodiment, the crystalline modification II of flufenacet according to the first aspect of the invention, exhibits the following reflexes:
- 2θ = 10.592 ± 0.2 (1)
- 2θ = 14.414 ± 0.2 (2)
- 2θ = 15.582 ± 0.2 (3)
- 2θ = 17.930 ± 0.2 (4) .
- In one preferred embodiment, the crystalline modification II of flufenacet according to the first aspect of the invention, exhibits the following reflexes:
- 2θ = 10.592 ± 0.2 (1)
- 2θ = 14.414 ± 0.2 (2)
- 2θ = 15.582 ± 0.2 (3)
- 2θ = 17.930 ± 0.2 (4)
- 2θ = 18.812 ± 0.2 (6)
- 2θ = 19.205 ± 0.2 (7) .
- In one preferred embodiment, the crystalline modification II of flufenacet according to the first aspect of the invention, exhibits the following reflexes:
- 2θ = 10.592 ± 0.2 (1)
- 2θ = 14.414 ± 0.2 (2)
- 2θ = 15.582 ± 0.2 (3)
- 2θ = 17.930 ± 0.2 (4)
- 2θ = 18.812 ± 0.2 (6)
- 2θ = 19.205 ± 0.2 (7)
- 2θ = 20.727 ± 0.2 (8)
- 2θ = 23.888 ± 0.2 (9) .
- In one preferred embodiment, the crystalline modification II of flufenacet according to the first aspect of the invention, exhibits the following reflexes:
- 2θ = 10.592 ± 0.2 (1)
- 2θ = 14.414 ± 0.2 (2)
- 2θ = 15.582 ± 0.2 (3)
- 2θ = 17.930 ± 0.2 (4)
- 2θ = 18.812 ± 0.2 (6)
- 2θ = 19.205 ± 0.2 (7)
- 2θ = 20.727 ± 0.2 (8)
- 2θ = 23.888 ± 0.2 (9)
- 2θ = 27.017 ± 0.2 (10)
- 2θ = 29.010 ± 0.2 (11) .
- In a second aspect, the present invention provides a crystalline modification II of flufenacet, the crystalline modification exhibiting an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1, ± 0.2%) of one or more of 1676.95, 1484.76, 1309.70, 1151.70, 1033.94 and 943.23 cm -1.
- In a third aspect, the present invention provides a crystalline modification II of flufenacet, the crystalline modification exhibiting a melting point of from 77.1℃.
- In a fourth aspect of the present invention provides a crystalline modification II of flufenacet exhibiting a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 76.0℃ and peak maximum at 77.1℃, more preferably with a melting enthalpy of 65.43 J/g.
- The crystalline modification II of flufenacet is useful in controlling plant growth. Accordingly, the present invention also provides compositions for controlling plant growth, such as weeds, comprising the crystalline modification II of flufenacet. In the compositions, flufenacet may be employed on its own, as a mixture with auxiliaries and carriers and/or as a mixture with other active compounds.
- In a further aspect, the present invention provides the use of the crystalline modification II of flufenacet in the control of undesirable plant growth.
- Still further, the present invention provide a method for controlling plant growth at a locus, the method comprising applying to the locus the crystalline modification II of flufenacet.
- BRIEF DESCRIPTION OF DRAWINGS
- The aspects of the present invention relating to the crystalline modification II of flufenacet will be described in more detail hereinbelow, having reference, where appropriate, to the accompanying figures, in which:
- Figure 1 is an X-ray powder diffraction (XRD) spectrum of the crystalline modification II of flufenacet;
- Figure 2 is an infrared (IR) spectrum of the crystalline modification II of flufenacet; and
- Figure 3 is a Differential Scanning Calorimetry (DSC) spectrum of the crystalline modification II of flufenacet.
- The crystalline modification II of flufenacet is readily comminuted and/or ground. This facilitates the preparation of a wide range of agrochemical formulations, such as suspension concentrates (SC) , oil-based suspension concentrates (OD) , water-dispersible granules (WG) and water-soluble granules (SG) .
- As noted above, in one embodiment, the crystalline modification II of flufenacet may be characterized as exhibiting at least three of the following reflexes, in any combination, as 2θ±0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-Kα radiation at 25 ℃:
- 2θ = 10.592 ± 0.2 (1)
- 2θ = 14.414 ± 0.2 (2)
- 2θ = 15.582 ± 0.2 (3)
- 2θ = 17.930 ± 0.2 (4)
- 2θ = 18.421 ± 0.2 (5)
- 2θ = 18.812 ± 0.2 (6)
- 2θ = 19.205 ± 0.2 (7)
- 2θ = 20.727 ± 0.2 (8)
- 2θ = 23.888 ± 0.2 (9)
- 2θ = 27.017 ± 0.2 (10)
- 2θ = 29.010 ± 0.2 (11)
- 2θ = 29.336 ± 0.2 (12)
- 2θ = 35.500 ± 0.2 (13)
- The crystalline modification II of flufenacet of the present invention is characterized by an X-ray powder diffractogram having at least three of the reflexes indicated above. Preferably, the crystalline modification II of flufenacet is one having at least four of the aforementioned reflexes, more preferably at least five of the aforementioned reflexes, still more preferably six, more preferably still seven, especially eight of the aforementioned reflexes, again in any combination thereof.
- An X-ray powder diffractogram of the crystalline modification II of flufenacet is shown in Figure 1, which will be described in detail hereinafter.
- In one preferred embodiment, the crystalline modification II of flufenacet exhibits at least three, more preferably four, still more preferably five, more preferably still six, especially seven, of the following reflexes, in any combination, as 2θ±0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-Kα radiation at 25℃:
- 2θ = 10.592 ± 0.2 (1)
- 2θ = 14.414 ± 0.2 (2)
- 2θ = 15.582 ± 0.2 (3)
- 2θ = 17.930 ± 0.2 (4)
- 2θ = 18.812 ± 0.2 (6)
- 2θ = 19.205 ± 0.2 (7)
- 2θ = 20.727 ± 0.2 (8)
- 2θ = 23.888 ± 0.2 (9)
- 2θ = 27.017 ± 0.2 (10)
- 2θ = 29.010 ± 0.2 (11)
- 2θ = 35.500 ± 0.2 (13) .
- In a preferred embodiment, the crystalline modification II of flufenacet exhibits all of the following reflexes, in any combination, as 2θ±0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-Kα radiation at 25℃:
- 2θ = 10.592 ± 0.2 (1)
- 2θ = 14.414 ± 0.2 (2)
- 2θ = 18.812 ± 0.2 (6)
- 2θ = 19.205 ± 0.2 (7)
- 2θ = 20.727 ± 0.2 (8)
- 2θ = 23.888 ± 0.2 (9)
- 2θ = 29.010 ± 0.2 (11) .
- A preferred crystalline modification II of flufenacet exhibits all of the reflexes listed above, in particular all of the reflexes (1) to (13) .
- The X-ray powder diffractogram of the crystalline modification II of flufenacet shown in Figure 1 was taken using a diffractometer with a reflection geometry in the range from 3° to 60° with increments of 0.03° using Cu-Ka radiation at 25℃.
- As noted above, in a second aspect, the present invention provides a crystalline modification II of flufenacet exhibiting an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1, ± 0.2%) of one or more of the following: 1676.95, 1484.76, 1309.70, 1151.70, 1033.94 and 943.23 cm -1.
- An infrared (IR) spectrum of the crystalline modification II of flufenacet is shown in Figure 2.
- All IR spectra data were obtained using the following acquisition parameters:
-
FT-IR spectrometer Bruker Tensor37 Diamond ATR unit from Specac Wavelength range 550 - 4000 cm -1 Resolution 4 cm -1 Number of scans 16 - A preferred crystalline modification II of flufenacet exhibits an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1, ± 0.2%) of two or more, preferably three or more, more preferably four of the following: 1676.95, 1484.76, 1309.70, 1151.70, 1033.94 and 943.23 cm -1. A preferred crystalline modification II of flufenacet exhibits an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1, ± 0.2%) having all of the aforementioned vibration peaks.
- In one embodiment, the crystalline modification II of flufenacet exhibits an X-ray powder diffractogram as described above for the first aspect of the invention and an infrared (IR) spectrum as described above for the second aspect of the present invention.
- As discussed above, a third aspect of the present invention provides a crystalline modification II of flufenacet, exhibiting a melting point of about 77.1℃.
- In one embodiment, the crystalline modification II of flufenacet exhibits a melting point of about 77.1℃ according to this third aspect of the invention, together with an X-ray powder diffractogram as described above for the first aspect of the invention and/or an infrared (IR) spectrum as described above for the second aspect of the present invention.
- As also discussed above, a fourth aspect of the present invention provides a crystalline modification II of flufenacet exhibiting a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 76.0℃ and peak maximum at 77.1℃, more preferably with a melting enthalpy of 65.43 J/g.
- In one embodiment, the crystalline modification II of flufenacet exhibits a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 76.0℃and peak maximum at 77.1℃ according to this fourth aspect of the invention, together with an X-ray powder diffractogram as described above for the first aspect of the invention and/or an infrared (IR) spectrum as described above for the second aspect of the present invention and/or a melting point as described above for the third aspect of the present invention.
- In one preferred embodiment, the crystalline modification II of flufenacet is characterized by an X-ray powder diffraction pattern substantially as shown in Figure 1, and/or characterized by an IR spectrum substantially as shown in Figure 2, and/or characterized by a DSC thermogram substantially as shown in Figure 3, and/or by a melting point of about 77.1℃.
- Flufenacet is available commercially. Methods for preparing flufenacet are well known in the art. One particularly suitable method for preparing flufenacet is described in US 4,968,342.
- In a fifth aspect, the present invention provides a method for preparing a crystalline modification II of flufenacet, the method comprising the steps of:
- i) heating a solution of flufenacet in a solvent system comprising a one or more solvents while stirring until dissolved completely;
- ii) precipitating the crystalline modification II of flufenacet from the solution; and
- iii) isolating the precipitated crystalline modification II of flufenacet.
- The solution of flufenacet may be provided in step i) by heating flufenacet in the solvent system while stirring until dissolved completely. The form of flufenacet used in this step may be any form of flufenacet other than the crystalline modification II. In one embodiment flufenacet heated in the solvent system in step i) is amorphous flufenacet.
- The solvent system employed in the method is one in which flufenacet is readily soluble and is one from which the crystalline modification II of flufenacet is crystallised. In this respect, it has been found that appropriate selection of the solvent system is required in order to yield flufenacet in the crystalline modification II. The solvent system yielding the crystalline modification II of flufenacet comprises one or more solvents selected from aliphatic, cycloaliphatic or aromatic hydrocarbons, cymene, petroleum fractions, and petroleum ether.
- Suitable aliphatic hydrocarbon solvents are known in the art. Preferred aliphatic hydrocarbon solvents include alkanes, more preferably C 5 to C 10 alkanes, especially C 5 to C 9 alkanes, for example pentane, hexane, heptane, octane and nonane. The aliphatic hydrocarbon solvents may be straight chained or branched, with straight chain or normal hydrocarbons being preferred, for example n-pentane, n-hexane, n-heptane, n-octane and n-nonane.
- Suitable cycloaliphatic hydrocarbon solvents are known in the art and include cycloalkanes, preferably C 5 to C 8 cycloalkanes. The cycloalkanes may be substituted, for example bearing one or more substituents, such as C 1 to C 4 alkyl-substituted cycloalkanes, especially cycloalkanes bearing one or more methyl substituents. Preferred cycloaliphatic hydrocarbon solvents include cyclohexane and substituted-cyclohexane, for example methylcyclohexane.
- Suitable aromatic hydrocarbon solvents are known in the art. The aromatic hydrocarbons may bear one or more substituents, such as one or more C 1 to C 4 alkyl moieties. Preferred aromatic hydrocarbon solvents are benzene and derivatives of benzene, such as cymene, toluene and xylene.
- Suitable petroleum fractions for use as solvents are known in the art. Preferred petroleum fractions are those having a boiling point of from 50 to 200℃, more preferably from 60 to 190℃, such as ligroin or heavy naphtha having a boiling point of from 90 to 140℃ or light naphtha having a boiling point from 60 to 80℃.
- One particularly preferred solvent is xylene.
- As noted above, it has been found that the crystalline form of flufenacet obtained by crystallization from a solution in a solvent system comprising one or more of the aforementioned solvents exhibits a significant and surprisingly lower toxicity.
- Accordingly, in a further aspect, the present invention provides the use of a solvent system to prepare crystalline flufenacet having reduced toxicity, wherein the solvent system comprises one or more solvents selected from aliphatic, cycloaliphatic or aromatic hydrocarbons, petroleum fractions, and petroleum ether.
- The solvent system may consist essentially of a single solvent selected from the aforementioned solvents. Alternatively, the solvent system may comprise a mixture of two or more of the aforementioned solvents, for example a mixture of three or four solvents.
- In step i) of the method, a solution of flufenacet in the solvent system is provided. As noted above, this may be achieved by heating flufenacet in the solvent system. The solvent system may be heated to a temperature above room temperature, for example to a temperature from 25℃, more preferably to a temperature from 30℃. The solvent system may be heated to a temperature up to the boiling point of the solvent system, preferably up to 90℃, more preferably up to 80℃, still more preferably up to 70℃, more preferably still up to 60°, depending upon the solvent system being employed. For example the solvent system may be heated to a temperature of from 30 to 60℃.
- The flufenacet is preferably combined with the solvent system while stirring until the flufenacet starting material is dissolved completely.
- In step ii) of the method, flufenacet is caused to precipitate from the solution to yield the crystalline modification II of flufenacet. Any suitable technique for precipitating flufenacet from the solution provided in step i) may be used.
- In one preferred embodiment, the solution of flufenacet in the solvent system is cooled. The solution may be cooled to any suitable temperature to cause the crystalline modification II of flufenacet to crystallise out of the solution. The solution may be cooled to a temperature of down to -20℃, preferably down to -15℃. The solution may be cooled to a temperature of up to 10℃, more preferably up to 5℃. Cooling to a temperature in the range of from -15 to 5℃ is preferred for many embodiments.
- Alternatively, or in addition to cooling, precipitation may be facilitated by removing solvent from the solution, for example by applying a vacuum to the solution.
- In one embodiment seed crystals are added to the solution. The addition of seed crystals facilitates precipitation of the solute from the solution, as is known in the art. Preferably, the seed crystals are crystals of flufenacet, more preferably crystals of the crystalline modification II of flufenacet.
- The amount of seed crystals added to the solution is typically in the range of from 0.001 to 10% by weight, preferably from 0.001% to 2.5% by weight, more preferably from 0.005 to 0.5%by weight, based on the weight of flufenacet present in the solution provided in step i) . The seed crystals are preferably added to the solution at a temperature below the boiling point of the solvent system.
- In step iii) of the method, the precipitated crystalline modification II of flufenacet is isolated or recovered from the solvent system. Any suitable technique may be used to recover the crystalline modification II of flufenacet, for example filtration, centrifugation and/or decantation.
- The isolated solid flufenacet is preferably washed one or more times with a solvent system comprising one or more solvents. Preferably, the solvent system employed in the washing stage comprises one or more components of the solvent system of the solution provided in step (i) , as described hereinbefore. Washing is preferably carried out using the solvent system at a temperature from 0℃ to room temperature, depending on the solubility of the crystalline form of flufenacet in the solvent, in order to minimize or avoid the loss of crystalline material in the corresponding washing solvent.
- The use of flufenacet as an herbicide is known in the art and is used on a commercial scale. It has been found that the crystalline modification II of flufenacet is also active in controlling undesirable plant growth, such as weeds. Techniques of formulating and applying amorphous flufenacet are known in the art, for example as disclosed in the prior art documents described hereinbefore. These techniques can also be applied in an analogous manner to the crystalline modification II of flufenacet.
- Accordingly, the present invention further provides a herbicidal composition comprising the crystalline modification II of flufenacet as defined hereinbefore.
- The herbicidal composition generally comprises one or more auxiliary components, as described in more detail hereinafter.
- The herbicidal composition may comprise the crystalline modification II of flufenacet in any suitable amount, which may depend upon such factors as the type of formulation being employed. Preferably, the comprises the crystalline modification II of flufenacet in an amount of up 90% by weight of the composition, preferably up to 75% by weight of the composition, more preferably up to 60% by weight of the composition. Preferably, the composition comprises the crystalline modification II of flufenacet in an amount of from 5% by weight of the composition, preferably from 10% by weight of the composition, more preferably from 20%by weight of the composition. In one preferred embodiment, the composition comprises the crystalline modification II of flufenacet in an amount of about 50% by weight of the composition.
- The composition may be formulated in any suitable form. Preferably, the composition is in the form of a suspension concentrate (SC) , an oil-based suspension concentrate (OD) , water-soluble granules (SG) , a dispersible concentrate (DC) , an emulsifiable concentrate (EC) , an emulsion seed dressing, a suspension seed dressing, granules (GR) , microgranules (MG) , a suspoemulsion (SE) or water-dispersible granules (WG) . The components and techniques required to form the aforementioned formulations are known in the art.
- In one preferred embodiment, the composition is in the form of a suspension concentrate (SC) . In a further preferred embodiment, the composition is in the form of water-dispersible granules (WG) .
- The compositions are prepared by combining the crystalline modification II of flufenacet with one or more agriculturally acceptable auxiliaries. The auxiliaries employed in the composition and their amounts will depend upon the type of formulation and/or the manner in which the formulation is to be applied by the end user. Suitable auxiliaries are customary formulation adjuvant or components, such as dispersants, wetting agents, emulsifiers, extenders, carriers, solvents, surfactants, stabilizers, anti-foam agents, anti-freeze agents, preservatives, antioxidants, colourants, thickeners, solid adherents and inert fillers. Such auxiliaries are known in the art and are commercially available. Their use in the formulation of the compositions of the present invention will be apparent to the person skilled in the art.
- Surfactants can be an emulsifier, dispersant or wetting agent of ionic or nonionic type.
- Examples which may be used include, but are not limited to, salts of polyacrylic acids, salts of lignosulphonic acid, salts of phenylsulphonic or naphthalenesulphonic acids, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols, especially alkylphenols, sulphosuccinic ester salts, taurine derivatives, especially alkyltaurates, or phosphoric esters of polyethoxylated phenols or alcohols.
- Liquid diluents include, but are not limited to, water, N, N-dimethylamide, dimethyl sulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, propylene carbonate, dibasic esters, paraffins, alkylbenzenes, alkyl naphthalenes, glycerine, triacetine, oils of olive, castor, linseed, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, acetates such as hexyl acetate, heptyl acetate and octyl acetate, and alcohols such methanol, cyclohexanol, decanol, benzyl and tetrahydrofurfuryl alcohol, and mixtures thereof.
- The composition may further comprise one or more polymeric stabilizers. Suitable polymeric stabilizers that may be used in the present invention include, but are not limited to, polypropylene, polyisobutylene, polyisoprene, copolymers of monoolefins and diolefins, polyacrylates, polystyrene, polyvinyl acetate, polyurethanes or polyamides. Suitable stabilizers are known in the art and are commercially available.
- The composition may further comprise one or more anti-foam agents. Suitable anti-foam agents include those substances which can normally be used for this purpose in agrochemical compositions and will be readily apparent to the person skilled in the art. Suitable anti-foam agents are known in the art and are commercially available. Particularly preferred anti-foam agents are mixtures of polydimethylsiloxanes and perfluroalkylphosphonic acids, such as the silicone anti-foam agents (for example commercially available from GE or Compton) . Other examples of anti-foam agents are fatty acids, tallow, and sodium salts.
- The composition may further comprise one or more preservatives. Suitable preservatives include those substances which can normally be used for this purpose in agrochemical compositions of this type and again are well known in the art. Suitable examples that may be mentioned include (commercially available from Bayer AG) and (commercially available from Bayer AG) .
- The composition may further comprise one or more antioxidants. Suitable antioxidants are substances which can normally be used for this purpose in agrochemical compositions, as is known in the art. Preference is given, for example, to butylated hydroxytoluene.
- The composition may further comprise one or more solid adherents. Such adherents are known in the art and available commercially. Suitable solid adherents include organic adhesives, including tackifiers, such as celluloses of substituted celluloses, natural and synthetic polymers in the form of powders, granules, or lattices, and inorganic adhesives such as gypsum, silica, or cement.
- The composition may further comprise one or more inert fillers. Such inert fillers are known in the art and available commercially. Suitable fillers include, for example, natural ground minerals, such as kaolins, aluminas, talc, chalk, quartz, attapulgite, montmorillonite, and diatomaceous earth, or synthetic ground minerals, such as highly dispersed silicic acid, aluminum oxide, silicates, and calcium phosphates and calcium hydrogen phosphates. Suitable inert fillers for granules include, for example, crushed and fractionated natural minerals, such as calcite, marble, pumice, sepiolite, and dolomite, or synthetic granules of inorganic and organic ground materials, as well as granules of organic material, such as sawdust, coconut husks, corn cobs, and tobacco stalks. Examples of inert fillers also include sodium tripolyphosphate and sucrose.
- Solid diluents can be water-soluble or water-insoluble. Water-soluble solid diluents include, but are not limited to, salts such as alkali metal phosphates (for example sodium dihydrogen phosphate) , alkaline earth phosphates, sulfates of sodium, potassium, magnesium and zinc, sodium and potassium chloride, sodium acetate, sodium carbonate and sodium benzoate, and sugars and sugar derivatives such as sorbitol, lactose, sucrose and mannitol. Examples of water-insoluble solid diluents include, but are not limited to clays, synthetic and diatomaceous silicas, calcium and magnesium silicates, titanium dioxide, aluminum, calcium and zinc oxide, and mixtures thereof.
- Wetting agents include, but are not limited to, alkyl sulfosuccinates, laureates, alkyl sulfates, phosphate esters, acetylenic diols, ethoxyfluornated alcohols, ethoxylated silicones, alkyl phenol ethyoxylates, benzene sulfonates, alkyl-substituted benzene sulfonates, alkyl a-olefin sulfonates, naphthalene sulfonates, alkyl-substituted naphthalene sulfonates, condensates of naphthalene sulfonates and alkyl-substituted naphthalene sulfonates with formaldehyde, and alcohol ethoxylates, and mixtures thereof. Alkyl naphthalene sulphonates, sodium salts are particularly useful for the composition of the invention.
- Dispersants include, but are not limited to, sodium, calcium and ammonium salts of ligninsulfonates (optionally polyethoxylated) ; sodium and ammonium salts of maleic anhydride copolymers; sodium salts of condensed phenolsulfonic acid; and naphthalene sulfonate-formaldehyde condensates. Ligninsulfonates such as sodium ligninsulfonates are particularly useful for the composition of the invention. Naphthalene sulfonate-formaldehyde condensates such as naphthalenesulfonic acid, polymers with formaldehyde, and sodium salts are particularly useful for the composition of the invention.
- Thickening agents include, but are not limited to, guar gum, pectin, casein, carrageenan, xanthan gum, alginates, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and carboxymethylcellulose, and mixtures thereof. Synthetic thickening agents include derivatives of the former categories, and also polyvinyl alcohols, polyacrylamides, polyvinylpyrrolidones, various polyethers, their copolymers, as well as polyacrylic acids and their salts, and mixtures thereof. Alkylpolyvinylpyrrolidones are particularly useful for the composition of the invention.
- Other formulation components can also be used in the present invention such as dyes, drying agents, and the like. These components and their uses are known to one skilled in the art.
- The composition of the present invention may comprise the crystalline modification II of flufenacet as the sole active ingredient. Alternatively, other active components may be present, such as attractants, sterilizing agents, bactericides, acaricides, nematicides, fungicides, growth-regulating substances, herbicides, safeners, fertilizers, semiochemicals, insecticides or agents for improving plant properties.
- The present invention also provides a method for controlling unwanted plant growth, comprising applying to the plant, plant part, or surroundings of the plant, a herbicidally effective amount of the crystalline modification II of flufenacet as hereinbefore described.
- The crystalline modification II of flufenacet is preferably applied in the form of a composition as hereinbefore described.
- Methods and techniques for applying the compositions of the present invention are known in the art and will be understood by the person skilled in the art. Techniques include diluting or dispersing the composition in a suitable diluent or carrier liquid, in particular water, and applying the composition by spraying.
- All plants, plant parts, and their surroundings can be treated with the crystalline modification II of flufenacet in accordance with the present invention. In the present context, plants are to be understood as meaning all plants and plant populations such as desired and undesired wild plants or crop plants, including naturally occurring crop plants. Crop plants can be plants which can be obtained by conventional breeding and optimization methods, by biotechnological and genetic engineering methods, or by combinations of these methods, including the transgenic plants and the plant cultivars which may or may not be protected by plant breeders' rights.
- Plant parts are to be understood as meaning all parts and organs of plants above and below the ground, such as shoots, leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes. Harvested materials, and vegetative and generative propagation materials, for example, cuttings, tubers, meristem tissue, rhizomes, offsets, seeds, single and multiple plant cells and any other plant tissues, are also included.
- Treatment of the plants, plant parts, and/or their surroundings, with the compositions or formulations of the invention can be carried out directly or by allowing the compositions or formulations to act on their surroundings, habitat or storage space by the customary treatment methods known in the art. Examples of these customary treatment methods include dipping, spraying, vaporizing, fogging, broadcasting, painting on in the case of propagation material, and applying one or more coats particularly in the case of seeds.
- The benefits of the present invention are particularly advantageous when the crystalline modification II of flufenacet or its herbicidal composition are applied to kill weeds in crops of useful plants, such as cereals, for example wheat, barley, rye, oats, maize, rice, sorghum, triticale and related crops; fruit, such as pomes, stone fruit and soft fruit, such as apples, grapes, pears, plums, peaches, almonds, pistachio, cherries, and berries, for example strawberries, raspberries and blackberries, bell pepper, red pepper; leguminous plants, for example beans, lentils, peas and soybeans; oil plants, such as rape, mustard and sunflowers; cucurbitaceae, such as marrows, cucumbers and melons; fiber plants, for example cotton, flax, hemp and jute; citrus, such as calamondin, citrus citron, citrus hybrids, including chironja, tangelo and tangor, grapefruit, kumquat, lemon, lime, mandarin (tangerine) , sour orange, sweet orange, pummelo, and satsuma mandarin; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes and paprika; coffee; and sugarcane; as well as ornamentals, including flowers, such as rose, shrubs, broad-leaved trees and evergreens, such as conifers. The crop plants are preferably cereals, in particular maize and rice, soybeans, cotton and potatoes.
- The invention may be used to control a wide range of undesired plants, including broadleaf plants and grassy weeds. The broadleaf weeds include such plants as shepherds purse (Capsella bursapastories) , fat hen (Chenopodium album) , double thorn (Oxygonum sinuatum) , black bind weed (Polygonum convolvulus) , Mexican marigold (Tagetes minuta) , gallant soldier (Galinsogo parviflora) , and white charlock (Raphanus raphanastrium) . The grassy weeds include such plants as foxtail (Setaria spp. ) , wild finder millet (Eleusine spp. ) , couch grass (Digitaria spp. ) and rye grass (Lolium spp. ) .
- Throughout the description and claims of this specification, the words “comprise” and variations of the words, for example “comprising” and “comprises” , mean “including but not limited to” , and do not exclude other moieties, additives, components, integers or steps. Moreover the singular encompasses the plural unless the context otherwise requires: in particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.
- In this specification, references to properties are, unless stated otherwise, to properties measured under ambient conditions, i.e. at atmospheric pressure and at a temperature of about 20℃.
- As used herein, the term “about” or "around" when used in connection with a numerical amount or range, means somewhat more or somewhat less than the stated numerical amount or range, and for example to a deviation of ± 10% of the stated numerical amount or endpoint of the range.
- “Surrounding, ” as used herein, refers to the place on which the plants are growing, the place on which the plant propagation materials of the plants are sown or the place on which the plant propagation materials of the plants will be sown.
- "Precipitation" as used herein, refers to the sedimentation of a solid material (a precipitate) , including the sedimentation of a crystalline material, from a liquid solution in which the solid material is present in amounts greater than its solubility in the amount of liquid solution.
- The term “herbicidally effective amount” as used herein, refers to the quantity of such a compound or combination of such compounds that is capable of producing a controlling effect on the growth of plants. The controlling effects include all deviation from the natural development of the target plants, for example killing, retardation of one or more aspects of the development and growth of the plant, leaf burn, albinism, dwarfing and the like.
- Embodiments of the present invention will now be described by way of the following examples, which are provided for illustrative purposes only.
- All percentages are given in weight percent, unless otherwise indicated.
- EXAMPLES
- Example 1
- Preparation of Flufenacet
- Flufenacet was prepared generally in accordance with the method of Example 1 of US 4,968,342, as follows:
- 11.8 g (0.05 mol) of 2-methylsulphonyl-5-trifluoromethyl-1, 3, 4-thiadiazole were dissolved in 100 mL of acetone together with 11.4 g (0.05 mol) of 4'-Fluoro-N-isopropylhydroxyacetanilide. A solution of 2.4 g of sodium hydroxide powder and 9 mL of water was slowly added dropwise at -20℃ with stirring. Stirring was then continued at -20℃ for 3 hours, after which the reaction mixture was poured into water.
- The solid flufenacet product was isolated by filtering with suction. Flufenacet obtained was amorphous.
- The reaction scheme can be represented as follow:
-
- Example 2
- Preparation of crystalline modification II of flufenacet (crystallization from xylene)
- Flufenacet prepared in Example 1 (10 g) was placed in a 3 neck round bottom flask, together with xylene (60 mL) . The resulting mixture was heated to a temperature of from 30 to 60℃ while stirring until the flufenacet had dissolved completely. Thereafter, the solution was slowly cooled to a temperature of from -15℃ to 5℃. Upon cooling, fine crystals formed. The slurry of crystals and solution was stirred at room temperature for 2 hours. Thereafter, the slurry was filtered and washed with xylene (3 mL) . The filtered crystals were dried under a vacuum at room temperature in order to remove the xylene traces from the crystalline product.
- The crystalline product thus obtained had a purity of >98% and the product recovered as crystals was found to be not less than 80% yield.
- The crystal product was analyzed by IR spectrometry, XRD and DSC and found to be crystalline modification II of flufenacet as shown in Figures 1, 2 and 3, respectively.
- The X-ray diffractogram of the crystal exhibited the reflexes as shown in Figure 1 and the values are summarized in Table 1 below.
- Table 1
-
- The IR spectrum of the crystalline flufenacet exhibited the functional group characteristic vibrations peaks at wavenumbers of one or more of about 1676.95, 1484.78, 1309.70, 1151.70, 1033.94 and 943.23 cm -1, as shown in Figure 2.
- The Differential scanning calorimetry (DSC) of the crystalline flufenacet exhibited an endothermic melting peak with onset at 76.0℃ and peak maximum at 77.1℃, with a melting enthalpy of 65.43 J/g, as shown in Figure 3.
- Example 3
- Preparation of Suspension Concentrate (SC) Formulation
- A suspension concentrate (SC) formulation was prepared as follows:
- All the components list in Table 2 below were mixed uniformly and the resulting mixture was ground with a Dyno-Mill (manufactured by Willy A. Bachofen AG) to obtain a suspension concentrate.
- Table 2
-
-
- Comparative Examples A to B
- To provide a comparison, the procedure of Example 2 above was followed to prepare crystalline flufenacet using a range of different solvents. The solvent employed in each case is indicated in Table 3 below.
- Table 3
-
Comparative Example Solvent A Ethanol B Methanol - Each of crystalline flufenacet products of Comparative Examples A and B was analysed and found to be crystalline form other the crystalline modification II.
- Example 4
- Preparation of Water Dispersible Granules (WG)
- Water dispersible granules (WG) were prepared as follows:
- All the components listed in Table 4 below were mixed, blended and milled in a high-speed rotary mill. Sufficient water was added to obtain an extrudable paste. The paste was extruded through a die or screen to form an extrudate. The wet extrudate was dried at 70℃ in a vacuum oven and then sifted through 0.71 mm to 2 mm screens to obtain the product granules.
- Table 4
-
-
- Example 5
- Toxicity test
- Sample preparation
- Samples prepared in Examples 1, 2, 3, 4 and samples of the flufenacet material of Comparative Examples A and B were used to prepare stock solutions (1 g/L) in dimethyl sulphoxide (DMSO) . Serial dilutions of the stock solutions were prepared in DMSO. The final concentration of flufenacet in the solutions was 0.5 mol/L. Concentrations are presented as nominal values.
- The toxicity of the resulting solutions to copepods was determined using the following procedure:
- Marine copepod culture preparation
- Copepods (A clausi) were placed in culture vessels (2.5 L plastic buckets) and maintained at 14 ± 1℃ in a temperature-controlled room under conditions of dim light, with a photoperiod of 14 hours light and 10 hours dark.
- Acute toxicity test
- The acute toxicity of the solutions to the marine copepods were investigated in 48-h static renewal tests using adult stages.
- Adult copepods were exposed in a series of tests to five toxicant concentrations, a control and with three replicates of 10 animals each per concentration. The animals were transferred to the test solutions using disposable Pasteur pipettes in a minimum of sea water to reduce dilution. The exposure vessels were each 50 mL borosilicate glass beakers containing 40 mL of test solution.
- The tests were undertaken in a temperature-controlled room (14 ± 1℃) under dim fluorescent light with a photoperiod of 14 hours light and 10 hours dark. The test end point was immobility of the animal, identified by a lack of movement when gently prodded or blown with a stream of water.
- Animals were checked for mobility after 48 hours by observation under a stereo microscope. The tests were considered successful if control survival was greater than 90%.
- Acute EC50 values were calculated using Probit or Spearman-Karber analyses using Tox Calc.
- The results are summarized in Table 5 below.
- Table 5
-
-
- As can be seen from the results set out in Table 5 above, the crystalline modification II of flufenacet exhibits a significantly lower toxicity than amorphous flufenacet and other crystalline forms of flufenacet.
Claims (25)
- A crystalline modification II of flufenacet, the crystalline modification exhibiting at least three of the following reflexes, in any combination, as 2θ±0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-Kα radiation at 25 ℃:2θ = 10.592 ± 0.2 (1)2θ = 14.414 ± 0.2 (2)2θ = 15.582 ± 0.2 (3)2θ = 17.930 ± 0.2 (4)2θ = 18.421 ± 0.2 (5)2θ = 18.812 ± 0.2 (6)2θ = 19.205 ± 0.2 (7)2θ = 20.727 ± 0.2 (8)2θ = 23.888 ± 0.2 (9)2θ = 27.017 ± 0.2 (10)2θ = 29.010 ± 0.2 (11)2θ = 29.336 ± 0.2 (12)2θ = 35.500 ± 0.2 (13) .
- The crystalline modification II of flufenacet according to claim 1, wherein the crystalline modification exhibits at least three, more preferably four, still more preferably five, more preferably still six, especially seven, of the following reflexes, in any combination, as 2θ±0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-Kα radiation at 25℃:2θ = 10.592 ± 0.2 (1)2θ = 14.414 ± 0.2 (2)2θ = 15.582 ± 0.2 (3)2θ = 17.930 ± 0.2 (4)2θ = 18.812 ± 0.2 (6)2θ = 19.205 ± 0.2 (7)2θ = 20.727 ± 0.2 (8)2θ = 23.888 ± 0.2 (9)2θ = 27.017 ± 0.2 (10)2θ = 29.010 ± 0.2 (11)2θ = 35.500 ± 0.2 (13) .
- The crystalline modification II of flufenacet according to either of claims 1 or 2, wherein the crystalline modification exhibits all of the following reflexes, in any combination, as 2θ±0.2 degree in an X-ray powder diffractogram (XRD) recorded using Cu-Kα radiation at 25℃:2θ = 10.592 ± 0.2 (1)2θ = 14.414 ± 0.2 (2)2θ = 18.812 ± 0.2 (6)2θ = 19.205 ± 0.2 (7)2θ = 20.727 ± 0.2 (8)2θ = 23.888 ± 0.2 (9)2θ = 29.010 ± 0.2 (11) .
- A crystalline modification II of flufenacet, the crystalline modification exhibiting an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1, ± 0.2%) of one or more of 1676.95, 1484.78, 1309.70, 1151.70, 1033.94 and 943.23 cm -1.
- A crystalline modification II of flufenacet, the crystalline modification exhibiting a melting point of 77.1C.
- A crystalline modification II of flufenacet, the crystalline modification exhibiting a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 76.0℃ and peak maximum at 77.1℃.
- A composition for controlling plant growth, the composition comprising the crystalline modification II of flufenacet according to any preceding claim.
- The composition according to claim 7, wherein the composition is in the form of a suspension concentrate (SC) , an oil-based suspension concentrate (OD) , water-soluble granules (SG) , a dispersible concentrate (DC) , an emulsifiable concentrate (EC) , an emulsion seed dressing, a suspension seed dressing, granules (GR) , microgranules (MG) , a suspoemulsion (SE) or water-dispersible granules (WG) .
- The composition according to either of claims 7 or 8, wherein the crystalline modification II of flufenacet is present in an amount of from 10 to 90% by weight.
- The composition according to any of claims 7 to 9, wherein the composition further comprises one or more auxiliaries selected from dispersants, wetting agents, emulsifiers, extenders, carriers, solvents, surfactants, stabilizers, anti-foam agents, anti-freeze agents, preservatives, antioxidants, colourants, thickeners, solid adherents and inert fillers.
- Use of the crystalline modification II of flufenacet according to any of claim 1 to 6 in the control of undesirable plant growth.
- A method for controlling plant growth at a locus, the method comprising applying to the locus the crystalline modification II of flufenacet according to any of claims 1 to 6 or a composition according to any of claims 7 to 10.
- The use of claim 11 or the method of claim 12, wherein the plant growth being controlled is in a crop of plants selected from cereals, for example wheat, barley, rye, oats, maize, rice, sorghum, triticale and related crops; fruit, such as pomes, stone fruit and soft fruit, such as apples, grapes, pears, plums, peaches, almonds, pistachio, cherries, and berries, for example strawberries, raspberries and blackberries, bell pepper, red pepper; leguminous plants, for example beans, lentils, peas and soybeans; oil plants, such as rape, mustard and sunflowers; cucurbitaceae, such as marrows, cucumbers and melons; fiber plants, for example cotton, flax, hemp and jute; citrus, such as calamondin, citrus citron, citrus hybrids, including chironja, tangelo and tangor, grapefruit, kumquat, lemon, lime, mandarin (tangerine) , sour orange, sweet orange, pummelo, and satsuma mandarin; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes and paprika; coffee; and sugarcane; as well as ornamentals, including flowers, such as rose, shrubs, broad-leaved trees and evergreens, such as conifers.
- The use of claim 11 or 13 or the method of claim 12 or 13, wherein the plant growth being controlled is that of a plant selected from shepherds purse (Capsella bursapastories) , fat hen (Chenopodium album) , double thorn (Oxygonum sinuatum) , black bind weed (Polygonum convolvulus) , Mexican marigold (Tagetes minuta) , gallant soldier (Galinsogo parviflora) , and white charlock (Raphanus raphanastrium) ; grassy weeds, such as foxtail (Setaria spp. ) , wild finder millet (Eleusine spp. ) , couch grass (Digitaria spp. ) and rye grass (Lolium spp. ) .
- A method for preparing a crystalline modification II of flufenacet, the method comprising the steps of:i) providing a solution of flufenacet in a solvent system comprising one or more solvents;ii) precipitating the crystalline modification II of flufenacet from the solution; andiii) isolating the precipitated crystalline modification II of flufenacet.
- The method according to claim 15, wherein amorphous flufenacet is used to prepare the solution of flufenacet in step i) .
- The method according to either of claims 15 or 16, wherein the solvent system comprises one or more solvents selected from aliphatic, cycloaliphatic or aromatic hydrocarbons, cymene, petroleum fractions, and petroleum ether.
- The method according to claim 17, wherein the solvent system comprises one or more solvents selected from alkanes, more preferably C 5 to C 10 alkanes, especially C 5 to C 9 alkanes, for example pentane, hexane, heptane, octane and nonane; C 5 to C 8 cycloalkanes, especially cyclohexane and methylcyclohexane; benzene and derivatives of benzene, such as cymene, toluene and xylene; and petroleum fractions having a boiling point of from 50 to 200℃, more preferably from 60 to 190℃, such as ligroin or heavy naphtha having a boiling point of from 90 to 140℃ or light naphtha having a boiling point from 60 to 80℃.
- The method according to any of claims 15 to 18, wherein in step i) the solvent system is heated to a temperature of from 25 to 90℃.
- The method according to any of claims 15 to 19, wherein in step ii) , the solution is cooled to a temperature of from -15 to 5℃.
- The method according to any of claims 15 to 20, wherein in step ii) a vacuum is applied to the solution.
- The method according to any of claims 15 to 21, wherein in step ii) seed crystals are added to the solution.
- The method according to claim 22, wherein the seed crystals are crystals of flufenacet, preferably the crystalline modification II of flufenacet.
- Use of a solvent system to prepare crystalline flufenacet having a reduced toxicity, wherein the solvent system comprises one or more solvents selected from aliphatic, cycloaliphatic or aromatic hydrocarbons, petroleum fractions, and petroleum ether.
- The use according to claim 24, wherein the solvent system comprises one or more solvents selected from alkanes, more preferably C 5 to C 10 alkanes, especially C 5 to C 9 alkanes, for example pentane, hexane, heptane, octane and nonane; C 5 to C 8 cycloalkanes, especially cyclohexane and methylcyclohexane; benzene and derivatives of benzene, such as cymene, toluene and xylene; and petroleum fractions having a boiling point of from 50 to 200℃, more preferably from 60 to 190℃, such as ligroin or heavy naphtha having a boiling point of from 90 to 140℃ or light naphtha having a boiling point from 60 to 80℃.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1918401.9A GB2592888A (en) | 2019-12-13 | 2019-12-13 | Novel crystalline forms of Flufenacet, methods for their preparation and use of the same |
PCT/CN2021/072800 WO2021115494A1 (en) | 2019-12-13 | 2021-01-20 | Novel crystalline forms of flufenacet, methods for their preparation and use of the same |
Publications (2)
Publication Number | Publication Date |
---|---|
EP4073049A1 true EP4073049A1 (en) | 2022-10-19 |
EP4073049A4 EP4073049A4 (en) | 2024-01-03 |
Family
ID=69186830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21731371.7A Pending EP4073049A4 (en) | 2019-12-13 | 2021-01-20 | Novel crystalline forms of flufenacet, methods for their preparation and use of the same |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4073049A4 (en) |
GB (1) | GB2592888A (en) |
WO (1) | WO2021115494A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2589919A (en) * | 2019-12-13 | 2021-06-16 | Rotam Agrochem Int Co Ltd | Novel crystalline forms of flufenacet, methods for their preparation and use of the same |
CN113575577A (en) * | 2021-08-17 | 2021-11-02 | 京博农化科技有限公司 | Auxiliary agent combination for preparing suspending agent, flufenacet water suspending agent and preparation method thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3821600A1 (en) * | 1988-06-27 | 1989-12-28 | Bayer Ag | HETEROARYLOXYACETIC ACID-N-ISOPROPYLANILIDE |
US5792872A (en) * | 1997-12-12 | 1998-08-11 | Bayer Corporation | Process for producing N-(4-fluorophenyl)-N-(1-methylethyl)-2- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl)oxy!acetamide |
US5895818A (en) * | 1997-12-12 | 1999-04-20 | Bayer Corporation | Process for making N-(4-fluorophenyl)-N-(1-methylethyl)-2- (5-trifuloromethyl)-1,3,4-thiadiazol-2-yl)oxy!acetamide using an aprotic, aromatic solvent |
US5852202A (en) * | 1997-12-12 | 1998-12-22 | Bayer Corporation | Process for isolating N-(4-fluorophenyl)-N-(1-methylethyl)-2- (5-trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy!acetamide |
DK201300088U1 (en) * | 2013-05-31 | 2013-07-12 | Andersen Tine | A product with useful properties |
CN103664824A (en) * | 2013-11-19 | 2014-03-26 | 泸州东方农化有限公司 | Preparation method of thiadiazole carboxamide compounds |
DK201300188U1 (en) * | 2013-12-03 | 2013-12-13 | Refsgaard Anne Marie Viktoria | Chemical compound with useful properties |
CN105646397A (en) * | 2014-11-27 | 2016-06-08 | 孙智华 | Preparation method of flufenacet |
EP3415507A1 (en) * | 2017-06-13 | 2018-12-19 | Solvay Sa | Process for the manufacture of aryl-thiadiazole-acetamide compounds |
EP3415506A1 (en) * | 2017-06-13 | 2018-12-19 | Solvay Sa | Process for the manufacture of haloalkyl substituted thiadiazole compounds |
GB2589919A (en) * | 2019-12-13 | 2021-06-16 | Rotam Agrochem Int Co Ltd | Novel crystalline forms of flufenacet, methods for their preparation and use of the same |
-
2019
- 2019-12-13 GB GB1918401.9A patent/GB2592888A/en active Pending
-
2021
- 2021-01-20 WO PCT/CN2021/072800 patent/WO2021115494A1/en unknown
- 2021-01-20 EP EP21731371.7A patent/EP4073049A4/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB201918401D0 (en) | 2020-01-29 |
WO2021115494A1 (en) | 2021-06-17 |
EP4073049A4 (en) | 2024-01-03 |
GB2592888A (en) | 2021-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021427503B2 (en) | Novel crystalline form of pyroxasulfone, methods for its preparation and use of the same | |
TWI735574B (en) | A novel form of sulfentrazone, a process for its preparation and use the same | |
CN106243175B (en) | Method for preparing novel crystal form of emamectin benzoate and application thereof | |
WO2021115494A1 (en) | Novel crystalline forms of flufenacet, methods for their preparation and use of the same | |
US20170247354A1 (en) | Novel form of rimsulfuron, a process for its preparation and use of the same | |
WO2017101515A1 (en) | Novel form of spirodiclofen, process for preparation and use thereof | |
WO2021115493A2 (en) | Novel crystalline forms of flufenacet, methods for their preparation and use of the same | |
US10947181B2 (en) | Crystalline form of tefluthrin, process for its preparation and use thereof | |
US9617247B1 (en) | Form of halosulfuron-methyl, a process for its preparation and use of the same | |
WO2017092469A1 (en) | Novel crystalline form of tribenuron-methyl, process for preparation and use thereof | |
US9643973B1 (en) | Crystalline form of diclosulam, a process for its preparation and use of the same | |
CN111132966B (en) | Novel forms of sulfometuron-methyl, process for their preparation and their use | |
WO2023051311A1 (en) | Crystalline form of diflufenican, process for its preparation and use of the same | |
WO2021175029A1 (en) | A novel form of metrafenone, a process for its preparation and use of the same | |
AU2016265996A1 (en) | A novel crystalline form of oxamyl, a process for its preparation and use of the same | |
US9663501B1 (en) | Process for preparing a novel crystalline form of thifensulfuron-methyl and use of the same | |
US10077248B2 (en) | Form of imazapyr, a process for its preparation and use the same | |
WO2023031810A1 (en) | Crystalline form of florasulam, preparation and use of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20220713 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20231204 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01N 43/82 20060101ALI20231128BHEP Ipc: C07D 285/13 20060101AFI20231128BHEP |